ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

STX Shield Therapeutics Plc

2.90
0.00 (0.00%)
Last Updated: 08:00:25
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.90 2.80 3.00 2.90 2.90 2.90 671,838 08:00:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 13.09M -33.29M -0.0320 -0.91 30.21M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 2.90p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 6.45p.

Shield Therapeutics currently has 1,041,690,484 shares in issue. The market capitalisation of Shield Therapeutics is £30.21 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.91.

Shield Therapeutics Share Discussion Threads

Showing 21726 to 21745 of 22025 messages
Chat Pages: 881  880  879  878  877  876  875  874  873  872  871  870  Older
DateSubjectAuthorDiscuss
22/12/2024
07:24
PATT it's more than 12.5 percentUnder the terms of the deal, Shield will receive an immediate £11 million upfront payment and is also in line to receive up to 4.5 million euros in short-term development milestones and up to 50 million euros in sales milestones..In addition, Shield will bank tiered royalties ranging from 25% to 40% of net sales of Feraccru..Those sales milestone were obviously set at stupid high amounts because none have come in. But it's 25-40 percent of Norgine sales. Nice to see this progress in UK and hope Germany is doing the same
skcots48
22/12/2024
02:08
Watch and learn. PURCHASEATTHETOP/ROBERT BOBARTH will leave this board in the near to short term stating the board lied just like pretty much every other stock he’s ramped since 2020 when he joined ADVFN. At the moment it’s clear he’s trying to rally the last remaining troops like ZEUS from Jaywick.
antonagis
21/12/2024
19:25
UK prescriptions rose to a record £115,344 in October 24 as compared to £60,923 in Oct 23


STX only get around 12% of that but the trend of sales is very encouraging.

purchaseatthetop
21/12/2024
16:13
Antonagis, your posts are like a broken record stuck on the world's most boring tune. If repetition was an art form, you'd be Picasso... but of pointless drivel.
zeus19
21/12/2024
11:06
Ken Finn. Head of recruitment. Stated about California new sales jobs…

“Great Opportunity in an expanded market”

purchaseatthetop
21/12/2024
05:16
R95055etc. I don’t expect any data till around 22/1/25 now with Q4 24 trading update. They did t seem concerned about getting the extra £1m from the retail book offer as that deadline has passed.
purchaseatthetop
20/12/2024
21:12
When is the Nov sales results?
r9505571
20/12/2024
14:44
They might get lucky with some large Dec orders before the break .But it's all speculation so we need hard numbers and to beat 31.5m
skcots48
20/12/2024
10:32
Best1467. I agree that it is very sensible to assume slight underperformance and see if that still works.
Given they got $225 in October and $192 in Aug snd Sept, it seems very conservative to model $200 in Q4. In which case they need 50k prescriptions which is about the standard 7k rise a quarter.

purchaseatthetop
20/12/2024
09:43
You keep quoting $220 that was average in October it’s not guaranteed across the full quarter let’s wait and see .I will be happy with anything above 192 across the Q4
best1467
20/12/2024
07:51
Skcots. They did $20m in the first nine months of 2024.
They have $1.5m of other royalties and milestone payments in Q4.
That means they need $10m in Q4 from US product sales
At $220 a pop that is 45,450 sales and they did 43k in Q3. So the rise would have to be tiny to miss the target.
Of course they are not just going to beat the target. They are going $1m beyond it I think.

purchaseatthetop
20/12/2024
07:48
AOP own nearly 60 percent of this company
So the listing of STX
Is 40 percent ownership of sales.
The above is to make it look simple
On the very intricate ownership and rights of STX
Management are basically diluting STX shareholders to oblivion
To the point of AOP taking full ownership

washingmachine
20/12/2024
07:42
They have a vote to pass a subscription that without winning they run out of money in 6 months and they aren't guaranteed 31.5m, all they told us was that they were on track in October .So yes uncertainty and why I responded to your post about it powering up
skcots48
20/12/2024
07:22
Al Cap .. there are certain crimes that most people find unforgivable. Patt is a poisonous human, no escaping that reality
dplewis1
20/12/2024
07:20
I am not so sure about uncertainty. We can be pretty sure they have hit $31m in 2024 with nearly $12m in Q4 with average Rx about $220 plus the new recruiting suggests prescription growth is strong. 2025 is going to be very interesting.
purchaseatthetop
20/12/2024
07:13
Sorry poor choice of word. Uncertainty
skcots48
20/12/2024
01:42
PURCHASEATTHETOP/RICHARD BOBARTH posted Wednesday saying strong rise Thursday in line with his unsubstantiated rubbish posted daily on many boards since 2020. What a fraud. Check this out….. www.mirror.co.uk/news/uk-news/conman-jailed-swindling-41000-working-8810621.amp
antonagis
19/12/2024
23:39
Skcots are you saying that AOP's new holding at 3p is an overhang? You expect them to dump their $10m new holding at 2.5p having just invested at 3p? (smacks own head)
cyberbub
19/12/2024
20:59
Give the fella a break ffsLet he who is free of sin cast the first stone
alancapone
19/12/2024
12:26
Skcots. Quite rightly nobody really trusts anything the BoD says because history is so bad! However the share price dropped heavily end Oct when they showed a drop in Rx from $170 to $167 or something like that. This was only due to the rogue July data. Since then every month sbove $200 which is quite amazing. Finally they are delivering but nobody quite believes it!
purchaseatthetop
Chat Pages: 881  880  879  878  877  876  875  874  873  872  871  870  Older